Breaking News
Top News
-
Russia Scales Back Annual Military Parade, Citing Threat From Ukraine
-
Mirova Green Fund Exits Philippine Debt After Graft Scandal
-
US Core Capital Goods Orders Rise by Most in Nearly Six Years
-
India Warns of Demand Hit to Economy After Iran War Boosts Costs
-
Why data storage stocks are a key AI play
-
Should You Be Bullish on Natera (NTRA)?
-
Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results
-
Robinhood’s crypto revenue tanks 47%, gap filled by prediction markets
-
Ex-Mars CEO named Lipton chair
-
Governor Sherrill Launches New Jersey Report Card Delivering on Day One Promise to Boost Transparency and Accountability in Trenton
-
AbbVie beats Q1 2026 earnings, raises full-year forecast
-
In A Victory, Gemini Put In Four Million GM Cars
-
Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)?
-
GE Vernova: This Brand New Energy Player Could Be the 1 Stock You’ll Wish You’d Bought in 2026
-
They Built A Career In Mechanical Engineering. Now They’re Stuck In The ‘Overqualified Trap’ And Can’t Even Get Hired At A Grocery Store
-
Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at
-
Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data
-
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why
-
Opes Wealth Sells Its Entire FIXD Stake — Is This $9.3 Million Bond ETF Exit A Signal?
-
H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
2026-02-05












